VitaSpring Biomedical Co. Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a VSBC research report →
Price Chart
About the company
VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine.
- CEO
- Jing-Zhou Chen
- IPO
- 2019
- Employees
- 1
- HQ
- Riverside, CA, US
Get TickerSpark's AI analysis on VSBC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.30M
- P/E
- -4.83
- PEG
- 0.04
- P/S
- 0.00
- P/B
- -0.49
- EV/EBITDA
- -20.55
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 10.15%
- ROIC
- 19.90%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $-9,957+0.0%
- Op Income
- $-385,411
- Net Income
- $-415,368+0.0%
- EPS
- $-0.00+0.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $1.00
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.17
- Beta
- -2.60
- RSI (14)
- 20
- Avg Volume
- 41
No earnings-call transcripts are available for VSBC yet.
- Free Float
- 47.2%
- Shares Outstanding
- 207.03M
- Float Shares
- 97.73M
Our VSBC coverage
Recent articles, reports, and earnings notes.
No research on VSBC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate VSBC report →